title: Successful treatment of multiple superficial basal cell carcinomas with topical imiquimod: case report and review of the literature.
abstract: BACKGROUND
  The use of imiquimod 5% cream for the treatment of superficial basal cell carcinoma (BCC) has been described. Its clinical efficacy was first shown in a study in patients with biopsy-proven superficial and nodular BCC.
  
  
  OBJECTIVE
  To evaluate the efficacy of topical imiquimod in a patient with multiple superficial BCCs unresponsive to topical 5-fluorouracil and to review the literature on this treatment modality for BCCs.
  
  
  RESULTS
  After 12 weeks of topical imiqmod, the patient's lesions had resolved. The patient was evaluated three months after discontinuation of treatment. There was no clinical evidence of any recurrent tumor.
  
  
  CONCLUSIONS
  Imiquimod 5% cream appears to be effective for multiple, superficial BCCs unresponsive to other modalities.
authors.affiliation: Department of Dermatology, St. Luke's-Roosevelt Hospital Center, New York, New York 10025, USA.
authors.forename: Molly M
authors.initials: MM
authors.lastname: Drehs
authors.forename: Fran
authors.initials: F
authors.lastname: Cook-Bolden
authors.forename: Elizabeth L
authors.initials: EL
authors.lastname: Tanzi
authors.forename: Jeffrey M
authors.initials: JM
authors.lastname: Weinberg
mesh_terms: D000287:Administration, Topical; D000634:Aminoquinolines / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002280:Basal Cell Carcinoma / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000077271:Imiquimod; D008875:Middle Aged; D012878:Skin Neoplasms / Q000188:drug therapy*
chemical_list: D000634:Aminoquinolines; D000970:Antineoplastic Agents; D000077271:Imiquimod